| Literature DB >> 36034094 |
Raul V Destura1, Hilton Y Lam2, Rohani C Navarro1, Jaifred Christian F Lopez2, Reneepearl Kim P Sales2, Ma Ida Faye A Gomez2, Angelo Dela Tonga1, Gianne Eduard Ulanday1.
Abstract
Introduction: The emergence of biological threats that can potentially affect millions emphasizes the need to develop a policy framework in the Philippines that can mount an adequate and well-coordinated response. The objective of the study was to assess, strengthen, and harmonize efforts in biorisk management through the development of a National Biorisk Management Framework.Entities:
Keywords: biorisk management; biosafety; biosecurity; policy analysis; policy gaps
Year: 2021 PMID: 36034094 PMCID: PMC9134340 DOI: 10.1089/apb.20.0070
Source DB: PubMed Journal: Appl Biosaf ISSN: 1535-6760
Figure 1.Methodology process.
Events and subevents in the tabletop exercise
| Response phase | |
| Event 1: Dead piglet brought to the RADDL for testing | Subevent 1.1: Initial laboratory testing for suspected ASF |
| Subevent 1.2: Samples negative for ASF and stored in refrigerator for next day | |
| Subevent 1.3: 36 pigs dead not reported to RADDL during weekend | |
| Subevent 1.4: Dead pigs of two more farmers brought in for testing | |
| Subevent 1.5: 6 farms affected with high pig mortality | |
| Activation phase | |
| Event 2: Samples brought to another laboratory for testing 250 km away | Subevent 2.1: Meat of dead pigs sold in the market |
| Subevent 2.2: Children getting sick | |
| Subevent 2.3: Analyst getting sick and not reporting in; samples missing from laboratory | |
| Subevent 2.4: 17 affected farms, pig mortality >50% | |
| Coordination phase | |
| Event 3: Confirmed diagnosis | Subevent 3.1: Local media asking for update |
| Subevent 3.2: Samples from vet reference laboratory positive for ASF | |
| Subevent 3.3: Pig carcasses buried on-site | |
| Subevent 3.4: Visit to analyst's home reveals samples used in “DIY home experiments” | |
ASF, African swine fever; RADDL, Regional Animal Disease Diagnostic Laboratory.
Four main policies and their objectives
| Four policies | Objectives |
|---|---|
| EO 514 Establishing the national biosecurity framework, prescribing guidelines for its implementation, strengthening the national committee on biosafety of the Philippines, and for other purposes | • Strengthen the existing science-based determination of biosafety to ensure the safe and responsible use of modern biotechnology |
| 1991 Philippine Biosafety Guidelines | Covers work involving genetic engineering, and activities requiring the importation, introduction, field release, and breeding of nonindigenous or exotic organisms even though these are not genetically modified |
| Cartagena Protocol on Biosafety | To contribute to ensuring an adequate level of protection in the field of the safe transfer, handling, and use of living modified organisms resulting from modern biotechnology that may have adverse effects on the conservation and sustainable use of biological diversity, taking also into account risks to human health, and specifically focusing on transboundary movements |
| UN Security Council Resolution 1540 (2004)—Permanent Mission of the Philippines to the United Nations | The Security Council decided that all states shall refrain from providing any form of support to nonstate actors that attempt to develop, acquire, manufacture, possess, transport, transfer, or use nuclear, chemical, or biological weapons and their means of delivery, in particular, for terrorist purposes. The resolution requires all states to adopt and enforce appropriate laws to this effect as well as other effective measures to prevent the proliferation of these weapons and their means of delivery to nonstate actors, in particular for terrorist purposes |
EO, executive order.
Summary of policies and regulatory subjects covered according to nine categories for developing sustainable capacity for biosafety and biosecurity in low-resource countries
| Entity | Country- or region-specific regulatory framework and guidelines or standards | Biosafety and biosecurity awareness | Infrastructure | Equipment, reagents, and services | Management processes and administrative controls | Training | Biosafety curricula | Biosafety association, professional competency, and credentialing | Individual mentoring and organizational twinning |
|---|---|---|---|---|---|---|---|---|---|
| All health products | ✓ | ✓ | |||||||
| Animal facilities | ✓ | ✓ | |||||||
| Animal transport | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
| Animals | ✓ | ✓ | ✓ | ✓ | |||||
| Biosafety policies, measures, guidelines | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
| Clinical laboratory | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
| Disease outbreaks | ✓ | ✓ | ✓ | ||||||
| Foreign rendering plants | ✓ | ||||||||
| Genetically modified plant and plant products | ✓ | ✓ | |||||||
| GMOs | ✓ | ✓ | ✓ | ||||||
| HIV testing laboratory | ✓ | ✓ | ✓ | ||||||
| Human stem cell and cell-based or cellular therapy facility | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
| Indigenous, exotic, and genetically modified arthropods | ✓ | ||||||||
| Inspection, testing and certifying bodies, and other bodies offering conformity assessment services | ✓ | ✓ | ✓ | ✓ | |||||
| Medical devices | ✓ | ✓ | |||||||
| Nonindigenous or exotic organisms | ✓ | ✓ | ✓ | ✓ | |||||
| Quarantine | ✓ | ✓ | ✓ | ✓ | |||||
| Specimens for confirmation testing of HFMD | ✓ | ||||||||
| Specimens for EVD testing | ✓ | ✓ | ✓ | ||||||
| Specimens for Leptospira spp | |||||||||
| Specimens for MERS-COV and novel influenza viruses | ✓ | ✓ | |||||||
| Specimens for TB testing | ✓ | ✓ | |||||||
| Tissue culture laboratories | ✓ | ✓ | ✓ | ||||||
| Veterinary clinics and hospitals | ✓ | ✓ | ✓ | ||||||
| Veterinary diagnostic laboratories | ✓ | ✓ | |||||||
| Veterinary drugs, products, biologics, medicinal preparation, and their establishments and outlets | ✓ | ✓ | ✓ | ||||||
| Weapons | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
| Total | 17 | 3 | 16 | 16 | 19 | 8 | 0 | 0 | 0 |
Heckert et al.[22]
EVD, Ebola virus disease; GMOs, genetically modified organisms; HFMD, hand, foot, and mouth disease; MERS-COV, Middle East respiratory syndrome coronavirus; TB, tuberculosis.
Ideal roles of identified stakeholders
| Ideal roles | Agency involved |
|---|---|
| Accrediting and auditing body for laboratories | Department of Trade and Industry |
| Background checks and vetting of laboratory workers | Intelligence agencies |
| • Calibration of laboratory equipment | Department of Science and Technology |
| Conduct of investigation on alleged bioterrorists | Department of the Interior and Local Government |
| • Creation of a National Emergency Response Team | Department of Health |
| • Creation of national action plan | • Anti-Terrorism Council |
| • Emergency response in disease outbreak in plants and animals | Department of Agriculture |
| Integration of biorisk management in curriculum and laboratory activities | • Commission on Higher Education |
| Regulation of entry and exit of BMCs | • Bureau of Customs |
| Regulation of transport of BMCs/infectious substances by land, water, and air | Department of Transportation |
BMC, biological materials of concern.
Resources available and adequacy of identified resources
| Adequacy | Agency |
|---|---|
| Adequate | • Anti-Terrorism Council |
| Current legislation does not include biorisk | Commission on Higher Education |
| Insufficient manpower | • Civil Service Commission |
| Lacking regional counterparts | Department of Agriculture |
| Limited capacity building efforts | Department of Agriculture |
| Limited experts on biosafety | • Commission on Higher Education |
| Limited funding | • Civil Service Commission |
| Limited in general | • University of the Philippines-National Institutes of Health |
| Meets minimum requirements | • Bureau of Fire Protection |
| Varies | • Civil society organizations |
Possible reaction to inclusion in framework
| Possible reaction | Stakeholder |
|---|---|
| Receptive | • Anti-Terrorism Council |
| Receptive with reservations | Department of Agriculture |
| Initially argumentative to eventually receptive | • Commission on Higher Education |
| Neutral | • Department of Science and Technology |
| Varies/mixed reactions | • Department of Interior and Local Government |
| Not sure/no consensus reached/no reaction identified | • Bureau of Customs |
Policy outcome activity results
| Policy outcome | Pros | Cons | Votes | % |
|---|---|---|---|---|
| Capacitating existing facilities to comply with the proposed policy | • Compliance improves quality | • Acceptability | 29 | 25.44 |
| Professionalization of biosafety officer/creation of plantilla | • Authority, recognition | • Greater responsibility | 27 | 23.68 |
| Enhancing the quality/outputs of laboratories | • General safety, client satisfaction | • Accountability | 20 | 17.54 |
| Penalize erring laboratories | • Income | • Cheating | 10 | 8.77 |
| Specialized unit for biorisk management | • Chance to become a certifying body | • Budget | 9 | 7.89 |
| Creation/regulation of Institutional Biosafety Committee | • Monitoring | • Authority | 8 | 7.02 |
| Trained personnel | • Compliance improves quality | • Acceptability | 5 | 4.39 |
| Controlling the number of new laboratories | • Easier management | • Failure to meet needs | 3 | 2.63 |
| Positive reinforcement | • Employee retention/promotion | • Academic dishonesty | 3 | 2.63 |
ABOT, Advanced Biosafety Officer Training; CPD, Continuing Professional Development.
Gap analysis results
| Response phase | Gaps identified | |
|---|---|---|
| Event 1: Dead piglet brought to the RADDL for testing | Subevent 1.1: Initial laboratory testing for suspected ASF | • Weak implementation of existing SOPs and policies |
| Subevent 1.2: Samples negative for ASF and stored in refrigerator for next day | ||
| Subevent 1.3: 36 pigs dead not reported to RADDL during weekend | ||
| Subevent 1.4: Dead pigs of two more farmers brought in for testing | ||
| Subevent 1.5: 6 farms affected with high pig mortality | ||
| Activation phase | ||
| Event 2: Samples brought to another laboratory for testing 250 km away | Subevent 2.1: Meat of dead pigs sold in the market | • Noncompliance to SOPs for the handling, transport, and referral of samples in larger distances to reference laboratories |
| Subevent 2.2: Children getting sick | ||
| Subevent 2.3: Analyst getting sick and not reporting in; samples missing from laboratory | ||
| Subevent 2.4: 17 affected farms, pig mortality >50% | ||
| Coordination phase | ||
| Event 3: Confirmed diagnosis | Subevent 3.1: Local media asking for update | • There is a need to ensure compliance to laboratory SOPs on divulging information to media |
| Subevent 3.2: Samples from vet reference laboratory positive for ASF | ||
| Subevent 3.3: Pig carcasses buried on-site | ||
| Subevent 3.4: Visit to analyst's home reveal samples used in “DIY home experiments” | ||
HR, human resource; SOPs, standard operating protocols.
Figure 2.Proposed National Biorisk Management Framework.